Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases

被引:0
|
作者
Bernath-Nagy, Dominika [1 ,2 ]
Kalinyaprak, Melek Suekran [2 ]
Giannitsis, Evangelos [2 ]
Abraham, Pal [1 ]
Leuschner, Florian [2 ,3 ]
Frey, Norbert [2 ,3 ]
Krohn, Jona Benjamin [2 ,3 ]
机构
[1] Semmelwe Univ, Heart & Vasc Ctr, Budapest, Hungary
[2] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany
[3] Heidelberg Univ, German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, Heidelberg, Germany
来源
关键词
extracellular vesicles; cardiovascular disease; diagnosis; prognosis; therapy; biomarker; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; MYOCARDIAL-INFARCTION; NONINVASIVE BIOMARKER; INTERNATIONAL SOCIETY; MICRORNA SIGNATURES; POSITION STATEMENT; EJECTION FRACTION; HEART-FAILURE; WORKING GROUP;
D O I
10.3389/fcvm.2024.1425159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) ranks among the primary contributors to worldwide mortality. Hence, the importance of constant research on new circulating biomarkers for the improvement of early diagnosis and prognostication of different CVDs and the development and refinement of therapeutic measures is critical. Extracellular vesicles (EV) have a great potential as diagnostic and prognostic markers, as they represent their parent cell by enclosing cell-specific molecules, which can differ in quality and quantity based on cell state. Assuming that all cell types of the cardiovascular system are capable of releasing EV into circulation, an emerging body of evidence has investigated the potential role of serum- or plasma-derived EV in CVD. Comprehensive research has unveiled alterations in EV quantity and EV-bound cargo in the form of RNA, proteins and lipids in the context of common CVDs such as coronary artery disease, atrial fibrillation, heart failure or inflammatory heart diseases, highlighting their diagnostic and prognostic relevance. In numerous in vitro and in vivo models, EV also showed promising therapeutic potential. However, translation of EV studies to a preclinical or clinical setting has proven to be challenging. This review is intended to provide an overview of the most relevant studies in the field of serum or plasma-derived EV.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Extracellular Vesicles in Cardiovascular Diseases: Diagnosis and Therapy
    Zhang, Xiaojing
    Wu, Yuping
    Cheng, Qifa
    Bai, Liyang
    Huang, Shuqiang
    Gao, Jun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [2] Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases
    de Freitas, Renata Caroline Costa
    Hirata, Rosario Dominguez Crespo
    Hirata, Mario Hiroyuki
    Aikawa, Elena
    BIOMOLECULES, 2021, 11 (03) : 1 - 20
  • [3] Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy
    Du, Yuxin
    Wu, Lin
    Wang, Litao
    Reiter, Russel J.
    Lip, Gregory Y. H.
    Ren, Jun
    CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 74 : 40 - 55
  • [4] Circulating extracellular vesicles as the source of diagnostic biomarkers for diseases
    Bied, Mathilde
    Pospichalova, Vendula
    Bleriot, Camille
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2022, 2 (04):
  • [5] Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases
    Lauren A. Newman
    Kate Muller
    Andrew Rowland
    Cellular and Molecular Life Sciences, 2022, 79
  • [6] Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases
    Newman, Lauren A.
    Muller, Kate
    Rowland, Andrew
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (05)
  • [7] CIRCULATING EXTRACELLULAR VESICLES AS A TOOL FOR DIAGNOSIS, PROGNOSIS AND MONITORING IN GLIOMA
    Ricklefs, Franz
    Wollmann, Kathrin
    Maire, Cecile
    Drexler, Richard
    Westphal, Manfred
    Lamszus, Katrin
    Duehrsen, Lasse
    NEURO-ONCOLOGY, 2022, 24 : 6 - 6
  • [8] Extracellular vesicles in diagnosis and therapy of kidney diseases
    Zhang, Wei
    Zhou, Xiangjun
    Zhang, Hao
    Yao, Qisheng
    Liu, Yutao
    Dong, Zheng
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 311 (05) : F844 - F851
  • [9] Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients
    Ricklefs, Franz L.
    Wollmann, Kathrin
    Salviano-Silva, Amanda
    Drexler, Richard
    Maire, Cecile L.
    Kaul, Michael G.
    Reimer, Rudolph
    Schueller, Ulrich
    Heinemann, Sarina
    Kolbe, Katharina
    Mummert, Tobias
    Glatzel, Markus
    Peine, Sven
    Gempt, Jens
    Westphal, Manfred
    Duehrsen, Lasse
    Lamszus, Katrin
    NEURO-ONCOLOGY, 2024, 26 (07) : 1280 - 1291
  • [10] Editorial commentary: Extracellular vesicles in cardiovascular diagnosis and therapy
    Hong, TingTing
    Shaw, Robin M.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2019, 29 (06) : 324 - 325